Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Protherics
Woman and Man
Between 18 years
and 99 years
Protherics
Update Il y a 4 ans
Protherics PR015-CLN-pro001 : Essai de phase 1-2 en escalade de dose évaluant la tolérance et l'efficacité de l'acadesine, chez des patients ayant une leucémie lymphocytaire chronique à cellules B. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions]
A Phase I/II Open Label Dose Escalation Study to Investigate the Safety and Tolerability of Acadesine in Patients With B-Cell Chronic Lymphocytic Leukemia.
Country
France
organs
Leucémies chroniques
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Protherics Medicines Development Ltd, a BTG plc company
Update Il y a 4 ans
A Randomized, Double Blind, Placebo Controlled Study of the Efficacy and Safety of Angiotensin Therapeutic Vaccine (ATV) in Patients With Mild to Moderate Hypertension
The Primary efficaccy objective of this study is to determine if immunization with ATV is effective in reducing mean daytime DBP measured by ambulatory blood pressure monitoring (ABPM) in subjects wit...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Protherics Development Medicines Ltd
Update Il y a 4 ans
A PHASE 2 STUDY OF THE ANTI-TUMOUR ACTIVITY AND SAFETY OF PROLARIX™ IN HEPATOCELLULAR CARCINOMA (HCC)
To evaluate the overall response rate [ie, proportion of subjects with complete response (CR) and partial response (PR)] to treatment with Prolarix at the MTD determined in a previous Phase 1 study (2...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Protherics Salt Lake City, Inc
Update Il y a 4 ans
A randomized study of the efficacy and safety of OncoGel™ treatment as an adjunctive therapy to systemic chemotherapy and concurrent external beam radiation prior to surgery in subjects with localized or loco-regional esophageal cancer
The primary objective of this clinical study is to evaluate the efficacy of OncoGel based on overall tumor response at the primary tumor site.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Protherics Medicines Development Ltd
Update Il y a 4 ans
Estudio de fase I/II abierto con aumento de la dosis para investigar la seguridad y tolerabilidad de acadesina en pacientes con leucemia linfocítica crónica de células B
To demonstrate the safety and tolerability of acadesine in patients with B-CLL.
Country
None
organs
None
Specialty
None
unknown
More information